Abstract categories
- Antiretroviral drugs preclinical
- Genomics
- HIV cure and reservoirs
- HIV diagnostics
- Immunology
- Pathogenesis and immunopathogenesis
- Vaccines and immune based therapies
- Virology
- Antiretroviral therapy – observational studies
- Antiretroviral therapy – randomised clinical trials
- Drug-drug interactions
- HIV drug resistance
- Pharmacology
- Toxicities
- Ageing and frailty
- Co-morbidities
- COVID-19 and HIV
- Neoplasia
- Mental health and quality of life
- Other co-infections
- Sexually transmitted infections
- Tuberculosis and other opportunistic infections
- Viral hepatitis and liver disease
- Men who have sex with men
- Men who have sex with women
- Transgender persons
- Women
- Adolescents
- Paediatrics
- Pregnancy and breastfeeding
- Vertical transmission
- Access and delivery of care
- Cascade of care
- Morbidity/mortality
- Prevalence, incidence and dynamics of HIV epidemics
- Standards of care
- Behavioural interventions
- HIV testing strategies, including co-testing
- Pre-exposure prophylaxis (PrEP)
- Post-exposure prophylaxis (PEP)
- Treatment as prevention
- Lifestyle interventions
- Migration
- People living with HIV involvement
- Social and behavioural science
- Sex workers
- Substance abuse
- Treatment in resource-constrained settings
- Vulnerable and marginalised groups
- Emerging infectious diseases
- War and other conflicts
Call for Science
Your opportunity to give the best exposure to your Abstracts, Clinical Cases and Late-Breaking science.
Please note that every deadline is until 23:59 (CET) of the same day.
| 15 March - 3 July 2023 |
Call for Abstract(s) |
|
15 March - 24 August 2023 |
Call for Clinical Case(s) |
| 20 July - 24 August 2023 |
Call for Late-Breaking Science |
Preparing your abstract?
Visit the EACS Resource Libary, your knowledge hub, and access on-demand webinars, past conference videos, slides to enhance your work.
